HTL Biotechnology

HTL Biotechnology is a global leader in the development and sustainable production of pharmaceutical-grade biopolymers such as hyaluronic acid and recombinant proteins. Its ingredients are used by over 100 clients in more than 30 countries across ophthalmology, dermatology, rheumatology, medical aesthetics, regenerative medicine, drug delivery systems and bioprinting. The company has pioneered biofermentation processes to produce high-quality non-animal-derived biopolymers with extensive safety records—over 400 million syringes of its hyaluronic acid have been used since 2006. It continues to expand manufacturing capacity and innovate with new sterile production lines enabling combination with heat-sensitive actives.